Deferred combined androgen blockade therapy using bicalutamide in patients with hormone-refractory prostate cancer during androgen deprivation monotherapy-Reference-Cited by-同舟云学术

Deferred combined androgen blockade therapy using bicalutamide in patients with hormone-refractory prostate cancer during androgen deprivation monotherapy

Published:2006-06 Issue:6 Volume:97 Page:1184-1189
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

FUJII YASUHISA,KAWAKAMI SATORU,MASUDA HITOSHI,KOBAYASHI TSUYOSHI,HYOCHI NOBUHIKO,KAGEYAMA YUKIO,KIHARA KAZUNORI

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2006.06149.x/fullpdf

Reference29 articles.

1. Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer

2. Orchiectomy versus goserelin and flutamide in the treatment of newly diagnosed metastatic prostate cancer. Analysis of the criteria of evaluation used in the european organization for research and treatment of cancer–-genitourinary group study 30853

3. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials

4. Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review;Cancers;2022-03-31

2. Management of nonmetastatic castration-resistant prostate cancer;Current Opinion in Supportive & Palliative Care;2018-09

3. Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel;Frontiers in Pharmacology;2017-11-22

4. A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer;European Journal of Cancer;2015-08

5. Castration-Resistant Prostate Cancer: AUA Guideline;Journal of Urology;2013-08